Pablo Vega
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Building a Brief Multidomain Questionnaire for Gambling Dual Disorder: Psychometric Validation and RDoC-Based Dimensional Structure.
Journal: International journal of methods in psychiatric research
Published: February 23, 2026
Evidence-based prevention of gambling dual disorder through clinical neuroscience and precision psychiatry.
Journal: International journal of psychiatry in clinical practice
Published: January 29, 2026
A population-based screening program provides insights into the characteristics and behaviors of individuals who self-refer for gambling disorder.
Journal: Spanish journal of psychiatry and mental health
Published: February 09, 2025
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder.
Journal: International clinical psychopharmacology
Published: September 25, 2024
Is there a risk of esketamine misuse in clinical practice?
Journal: Therapeutic advances in drug safety
Published: August 06, 2024
Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profiles.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: June 28, 2022
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment.
Journal: Neuropsychiatric disease and treatment
Published: January 17, 2022
Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.
Journal: Actas espanolas de psiquiatria
Published: July 01, 2021
Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective.
Journal: Frontiers in psychiatry
Published: July 30, 2020
Professional perception of clozapine use in patients with dual psychosis.
Journal: Actas espanolas de psiquiatria
Published: May 01, 2020
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study.
Journal: Drugs - real world outcomes
Published: March 01, 2020
Last Updated: 09/26/2026